← Open Payments lookup

MELISSA NURRENBERN: Open Payments

NPI 1538936984 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,545 in 68 payments from 18 companies in 2025. Trend: 2023 $139 · 2024 $1,423 · 2025 $1,545

Food & beverage: $1,545
CompanyPaymentsAmount
Madrigal Pharmaceuticals9$312
Takeda Pharmaceuticals U.S.A., Inc.9$221
ABBVIE INC.12$221
Janssen Biotech, Inc.8$164
GENZYME CORPORATION4$103
PFIZER INC.5$100
QOL Medical, LLC3$56
Ardelyx, Inc.2$53
Phathom Pharmaceuticals, Inc.3$51
Gilead Sciences, Inc.2$42

Products named: REZDIFFRA, RINVOQ, TREMFYA, ENTYVIO, DUPIXENT, VELSIPITY, Sucraid, EOHILIA.

Industry payments across IN — which companies pay providers there.